DM0000: The mark consists of the stylized lettering "IMPRIMIS" underlined with letters "RX" positioned to the right. The wording "A HARROW COMPANY" is positioned under "PRIMIS".
GS0051: Pharmaceutical compositions for ophthalmological use; topical anesthetic gel for ophthalmological use
CC0000: Color is not claimed as a feature of the mark.
GS0441: Pharmaceutical compounding services
DS0000: "RX" and "COMPANY"
Case File Event Statements
3/5/2024 - 11 months ago
1 - NEW APPLICATION ENTEREDType:NWAP
6/18/2024 - 7 months ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSC
6/18/2024 - 7 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
9/5/2024 - 5 months ago
4 - ASSIGNED TO EXAMINERType:DOCK
9/12/2024 - 4 months ago
6 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
9/12/2024 - 4 months ago
8 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
9/12/2024 - 4 months ago
7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
9/12/2024 - 4 months ago
5 - EXAMINERS AMENDMENT -WRITTENType:CNEA
9/17/2024 - 4 months ago
9 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
10/2/2024 - 4 months ago
10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
10/22/2024 - 3 months ago
11 - PUBLISHED FOR OPPOSITIONType:PUBO
10/22/2024 - 3 months ago
12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
12/3/2024 - 2 months ago
13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM